XTL BIOPHARMACEUTICALS LTD.
XTL Biopharmaceuticals Ltd is a clinical-stage biotech company focused on the development of pharmaceutical products for the treatment of autoimmune diseases including lupus. The Company’s lead drug candidate, hCDR1, is a world-class clinical asset for the treatment of systemic lupus erythematosus (SLE). Treatments currently on the market for SLE are not effective enough for most patients and some have significant side effects. Robust clinical data on hCDR1 has been produced in three clinical trials with 400 patients and over 200 preclinical studies with data published in more than 40 peer reviewed scientific journals.
XTL BIOPHARMACEUTICALS LTD.
Industry:
Biotechnology Developer Platform Pharmaceutical
Founded:
1993-01-01
Address:
Herzliya, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.xtlbio.com
Total Employee:
1+
Status:
Active
Contact:
+972 9-955-7080
Email Addresses:
[email protected]
Total Funding:
2.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt WordPress Apache Wordpress Plugins Mobile Non Scaleable Content Microsoft Exchange Online PHP
Similar Organizations
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Current Employees Featured
Stock Details
Official Site Inspections
http://www.xtlbio.com Semrush global rank: 5.94 M Semrush visits lastest month: 1.39 K
- Host name: 104.21.16.1
- IP address: 104.21.16.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
